ERBB2 and neoplasm: The tumor development of PyMT tumors is well-characterized, with tumor cells decreasing ER/PR expression and increasing HER2 levels when the tumor develops into mammary intraepithelial neoplasia (MIN) and late carcinoma (Lin et al., 2003[35]).